市场调查报告书
商品编码
1308169
血糖试纸市场:2023-2028年全球行业趋势、份额、规模、增长、机会及预测Blood Glucose Test Strips Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
2022年,全球血糖试纸市场规模达到116亿美元。展望未来,IMARC集团预计到2028年,该市场规模将达到189亿美元,2023-2028年期间的年复合增长率(CAGR)为8.2%。
血糖试纸是指用于监测血糖水平和控制糖尿病症状的小型一次性塑料或纸质试纸。血糖试纸由聚烯烃、聚酰胺、聚砜和纤维素材料制成。血糖试纸由多种成分组成,如亲水性、粘合剂、传感器、酶和电极层。它们还浸泡在葡萄糖氧化酶中,葡萄糖氧化酶与血样中的葡萄糖发生反应,从而显示血糖水平。除此之外,血糖试纸使用方便,成本效益高,可每天使用。因此,血糖试纸有助于识别高血糖或低血糖水平,监测糖尿病治疗效果,降低发生低血糖和/或高血糖的风险。
糖尿病发病率不断上升,尤其是在不断增长的老年人口中,这为市场带来了积极的前景。因此,血糖试纸被广泛用于在家中定期检测血糖水平,而无需前往诊断实验室,这为市场增长提供了支持。此外,由于血糖仪易于获得、操作方便、准确度高,产品在2型糖尿病患者中的广泛应用也有利于市场增长。此外,在冠状病毒病(COVID-19)大流行期间,血糖监测设备和试纸等耗材的需求和在线销售大幅增加。这可归因于作为预防措施和记录感染后症状,患者和普通人对持续监测血糖水平的需求不断增加,这反过来又促进了市场增长。其他因素,包括生物医学工程领域广泛的研发活动、不断变化的生活方式和饮食习惯,以及政府实施的各种以教育大众了解糖尿病及其预防措施为重点的倡议,预计将推动市场增长。
The global blood glucose test strips market size reached US$ 11.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 18.9 Billion by 2028, exhibiting a growth rate (CAGR) of 8.2% during 2023-2028.
Blood glucose test strips refer to small, disposable plastic or paper strips used to monitor blood glucose levels and control diabetes symptoms. They are manufactured using polyolefin, polyamide, polysulfone and cellulose materials. A blood glucose test strip comprises several components, such as hydrophilic, adhesive, sensors, enzymes and electrode layers. They are also soaked in glucose oxidase that reacts with glucose present in the blood sample to indicate sugar levels. Apart from this, blood glucose test strips are easy to use, cost-effective, and can be used daily. Consequently, they assist in identifying high or low blood sugar levels, monitoring the effectiveness of diabetes treatment, and lowering the risks of developing hypoglycemia and/or hyperglycemia.
The increasing prevalence of diabetes, especially among the growing geriatric population is creating a positive outlook for the market. In line with this, blood glucose test strips are widely used to test sugar levels regularly at home, while eliminating the need to visit a diagnostic laboratory, which is supporting the market growth. Additionally, the widespread product adoption among type-2 diabetic patients due to the easy availability of glucometers, convenient handling, and the level of accuracy provided by the machine are favoring the market growth. Moreover, the demand and online sales for blood glucose monitoring devices and consumables, such as test strips significantly surged during the coronavirus disease (COVID-19) pandemic. This can be attributed to the increasing need to continuously monitor sugar levels in patients and commoners both as a precautionary measure and to record post-infection symptoms, which, in turn, is augmenting the market growth. Other factors, including extensive research and development (R&D) activities in the field of biomedical engineering, evolving lifestyles and eating habits, and the implementation of various government initiatives focusing on educating the masses regarding diabetes and its preventive measures, are anticipated to drive the market toward growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global blood glucose test strips market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, technology, distribution channel and end user.
Thick Film Electrochemical Films
Thin Film Electrochemical Films
Optical Strips
Glucose Dehydrogenase (GDH)
Glucose Oxidase (GOD)
Online
Offline
Individuals
Hospitals and Clinics
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being 77 Elektronika Kft., Abbott Laboratories, AgaMatrix Inc., Ascensia Diabetes Care Holdings AG (PHC Holdings), B. Braun Melsungen Aktiengesellschaft, Bioland Technology Ltd., Bionime Corporation, BTNX Inc., Microlife Corporation (Midas Company Limited), Norditalia Group S.R.L., Rossmax International Ltd. and Unistrip Technologies LLC.